Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 15 Jun 2026 for Corvus Pharmaceuticals, Inc., €216k.
Filing timeline
BuySaleDavid Scott Moore
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -9.1%Entry US$11.74 · Close 22 Oct 2026 US$10.67
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
David Scott Moore: trading record in brief
Our data holds just one disclosure by David Scott Moore, dated 15 June 2026, reporting an open-market purchase worth €216k in Corvus Pharmaceuticals, Inc. Further filings will be added here. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to David Scott Moore
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
21,700 shares@ US$11.5316100.0% of flowCommon StockSEC:0001610717-26-000223:0
Canonical exit: 9 Sept 2026 (T+90)
1 of 1 declaration
